At the Forefront of Cancer Research

Catholic Health is pushing the boundaries in cancer treatment. 

The Future of Cancer Therapy

Clinical trials play an essential role in the fight against cancer. They are the only scientific way to prove a new treatment works better than the current standard of care. Some clinical trials test a drug, a medical device or a new way of doing surgery. Other trials test new ways to prevent disease, diagnose cancer or improve quality of life. Talk with your Catholic Health oncologist to decide if a clinical trial is right for you.

 

Current Open Clinical Trials

DEBRA: A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation For Conservative Treatment of Stage I, Hormone Sensitive. HER2-Negative, Oncotype Recurrence Score ≤ 18 Breast Ca

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions

View breast cancer services

A phase I/II Basket Trial of the EGF Vaccine CIMAvax in combination with the Anti-PD1 therapy in patients with advanced non-small cell lung cancer or squamous head and neck cancer.

NIGHTINGALE: Clinical Utility of Management of Patients with CT and LDCT Identified Pulmonary Nodules using the Percepta Nasal Swab Classifier – with Familiarization

A phase I/II Basket Trial of the EGF Vaccine CIMAvax in combination with the Anti-PD1 therapy in patients with advanced non-small cell lung cancer or squamous head and neck cancer.

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

 
A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)

Randomized Phase III Study of Combination AZD9291 (osimertinib) and Bevacizumab versus AZD9291 (osimertinib) Alone as First-Line Treatment for Patients with Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

Integration of Immunotherapy into adjuvant therapy for resected NCLC: ALCHEMIST CHEMO-IO (ACCIO)

S1914 A Randomized Phase III Trial of Induction/Consolidation Atezolizumab + SBRT versus SBRT Alone in High Risk, Early Stage NCSLC

 

View lung cancer services

ASTEROID- Assessing Single-Fraction SBRT versus Standard Palliative Radiation in Patients with Metastatic Disease

Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin

A Phase 2 Clinical Trial of an Artificial Intelligence–Derived Histological Biomarker to Select Neoadjuvant Treatment for Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma

St. Francis Hospital Cardio-Oncology Registry 

  • Principal Investigator: Dr. Haoyi Zheng

Phase 2 Open-label Study Evaluating the Efficacy and Safety of Luveltamab Tazevibulin (STRO-002) in Women with Relapsed Platinum-resistant Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal Cancers) Expressing Folate Receptor alpha (FOLR1)

A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy

Request More Information About Clinical Trials

Preferred Method of Contact

Clinical Excellence. Compassionate Care.

Cancer Services

Diagnosis and treatment for all types and stages of cancer.

Catholic Health Cancer Care Team

Board-certified oncologists and a supporting team of cancer specialists.

Catholic Health Cancer Institutes

Comprehensive cancer services at locations across Long Island.